JACoW is a publisher in Geneva, Switzerland that publishes the proceedings of accelerator conferences held around the world by an international collaboration of editors.
@inproceedings{mandrillon:cyclotrons2022-thbi01,
author = {J. Mandrillon and M. Abs and P. Cailliau and O. Cosson and S. Deprez and X. Donzel and G. Goosse and Y. Jongen and W.J.G.M. Kleeven and L.C.L. Koffel and L. Maunoury and V. Nuttens and Y. Otu and Y. Paradis and Ph. Velten},
% author = {J. Mandrillon and M. Abs and P. Cailliau and O. Cosson and S. Deprez and X. Donzel and others},
% author = {J. Mandrillon and others},
title = {{Status on NHa C400 Cyclotron for Hadrontherapy}},
% booktitle = {Proc. CYCLOTRONS'22},
booktitle = {Proc. 23rd Int. Conf. Cyclotrons Appl. (CYCLOTRONS'22)},
pages = {264--268},
paper = {THBI01},
language = {english},
keywords = {cyclotron, extraction, proton, resonance, hadron},
venue = {Beijing, China},
series = {International Conference on Cyclotrons and their Applications},
number = {23},
publisher = {JACoW Publishing, Geneva, Switzerland},
month = {10},
year = {2023},
issn = {2673-5482},
isbn = {978-3-95450-212-7},
doi = {10.18429/JACoW-CYCLOTRONS2022-THBI01},
url = {https://jacow.org/cyclotrons2022/papers/thbi01.pdf},
abstract = {{C400 is an isochronous cyclotron for cancer therapy delivering high dose rates of alphas to carbons at 400 MeV/amu extracted by electrostatic deflector and protons at 260 MeV extracted by stripping of molecular hydrogen. IBA started to pre-design the system more than 13 years ago in collaboration with JINR. The responsibility for the development of C400 has meanwhile been taken over by the French company Normandy Hadontherapy (NHa). However, the study and design work continued with a very strong involvement of IBA for the past 3 years, from concept on paper to reality. We will describe the most innovative concepts and technical solutions on the accelerator from source to extraction and show the construction progress.}},
}